| Literature DB >> 35739946 |
Alejandro Rojas-García1, Eduardo Fuentes2, María de la Luz Cádiz-Gurrea1, Lyanne Rodriguez2, María Del Carmen Villegas-Aguilar1, Iván Palomo2, David Arráez-Román1, Antonio Segura-Carretero1.
Abstract
Avocado seed and peel are the main by-products from avocado industrialisation, and account for nearly 30% of fruit weight. Although they are usually discarded, their high phenolic content has been deeply associated with several nutritional and functional benefits. Thus, for a comprehensive analytical evaluation of both semi-industrial extracts, various steps have been developed: tentative characterisation and quantification of the phenolic composition using HPLC-ESI-qTOF-MS, determination of TPC and antioxidant activity by Folin-Ciocalteu, FRAP, TEAC and ORAC methods, evaluation of scavenging capacity against different ROS and measurement of the enzymatic inhibitory potential against potentially harmful enzymes. Finally, their bioactive potential was tested in a human platelet model where antiaggregatory activity was measured. Hence, 48 different compounds were identified, where flavonoids and procyanidins were the most representative groups. The higher TPC was found in avocado peel extract (190 ± 3 mg/g), which showed more antioxidant power and more capacity to decrease ROS generation than seed extract (60 ± 2 mg/g). In addition, both extracts showed enzymatic inhibition, especially against hyaluronidase, xanthine oxidase and acetylcholinesterase. Lastly, avocado peel was proven to inhibit platelet aggregation with significant results at 1, 0.75 and 0.5 mg/mL, where the extract showed reducing effects on agonists' expression such as p-selectin or GPIIb/IIIa complex. These results demonstrate that both semi-industrial extracts-above all, avocado peel-have an interesting potential to be exploited as a natural by-product with antioxidant properties with multiple applications for the prevention of different pathologies.Entities:
Keywords: HPLC-MS; avocado by-products; enzyme inhibition; phenolic compounds; platelet aggregation; reactive oxygen species
Year: 2022 PMID: 35739946 PMCID: PMC9220077 DOI: 10.3390/antiox11061049
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Quantification data of identified phenolic compounds from avocado seed and peel.
| Standard | LOD | LOQ | Calibration Range (mg/L) | Calibration Equations | R2 |
|---|---|---|---|---|---|
| Quinic acid (1) | 0.04 | 0.14 | (0.977–7.813) | y = 1099.56 x − 21.48 | 0.999 |
| Quinic acid (2) | 0.04 | 0.14 | (3.906–31.25) | y = 2155.60 x − 5059.59 | 0.99 |
| Procyanidin B1 (1) | 0.37 | 0.95 | (0.977–3.906) | y = 336.61 x − 39.08 | 0.999 |
| Procyanidin B1 (2) | 0.37 | 0.95 | (3.906–15.625) | y = 857.10 x − 1913.35 | 0.998 |
| Catechin | 0.46 | 1.43 | (1.953–31.25) | y = 857.50 x − 748.37 | 0.999 |
| Quercetin | 0.08 | 0.19 | (0.488–31.25) | y = 3177.80 x − 2495.07 | 0.997 |
| Quercetin glucoside | 0.09 | 0.29 | (0.488–31.25) | y = 2820.85 x + 688.34 | 0.993 |
| Myrecetin-3-glucoside | 0.18 | 0.48 | (0.488–15.625) | y = 1289.08 + 737.99 | 0.995 |
| Verbascoside | 0.09 | 0.29 | (0.488–15.625) | y = 2199.92 x − 213.06 | 0.998 |
Limit of detection (LOD) and quantification (LOQ), patterns used to quantify for each compound, linear equations and the coefficient of variation (R2).
Identification and quantification of phytochemical compounds in avocado seed and peel extracts with ethanol/water by HPLC-ESI-qTOF-MS.
| Peak | RT (min) | [M-H]− | Mol. Formula | Compound | Content (mg/g DE) |
|---|---|---|---|---|---|
|
| |||||
| 1 | 0.46 | 343.0352 | C14H16O10 | Galloylquinic acid | 4.0 ± 0.1 |
| 2 | 0.62 | 211.0805 | C7H16O7 | Perseitol | NQ |
| 3 | 0.68 | 191.0546 | C7H12O6 | Quinic acid | 3.3 ± 0.4 |
| 4 | 0.78 | 191.0539 | C6H8O7 | Citric acid | 1.8 ± 0.3 |
| 5 | 4.28 | 597.2170 | C28H38O14 | Picraquassioside C | NQ |
| 6 | 4.41 | 351.0695 | C16H16O9 | Chlorogenoquinone isomer 1 | NQ |
| 7 | 5.38 | 443.1907 | C21H32O10 | Penstemide | NQ |
| 8 | 6.05 | 351.0705 | C16H16O9 | Chlorogenoquinone isomer 2 | NQ |
| 9 | 6.38 | 387.1643 | - | Unknown | NQ |
| 10 | 8.66 | 441.1741 | C21H30O10 | Hydroxyabscisic acid glucoside | NQ |
| 11 | 8.81 | 863.1824 | C45H36O18 | Procyanidin A trimer isomer 1 | NQ |
| 12 | 9.87 | 863.1804 | C45H36O18 | Procyanidin A trimer isomer 2 | 2.5 ± 0.3 |
| 13 | 10.12 | 863.1821 | C45H36O18 | Procyanidin A trimer isomer 3 | 2.7 ± 0.5 |
| 14 | 11.29 | 472.1606 | - | Unknown | NQ |
| 15 | 12.11 | 461.2371 | - | Unknown | NQ |
| 16 | 15.07 | 329.2321 | C18H34O5 | Trihydroxyoctadecenoic acid | NQ |
| 17 | 16.01 | 329.2330 | C18H34O5 | Trihydroxyoctadecenoic acid | NQ |
| 18 | 17.68 | 315.2522 | C14H20O8 | Hydroxy salidroside | NQ |
|
|
| ||||
|
| |||||
| 1 | 0.46 | 343.0360 | C14H16O10 | Galloylquinic acid | 3.1 ± 0.1 |
| 2 | 0.67 | 191.0544 | C7H12O6 | Quinic acid | 5.7 ± 0.7 |
| 3 | 0.78 | 191.0542 | C6H8O7 | Citric acid | 2.0 ± 0.3 |
| 4 | 0.83 | 545.0979 | C14H20O7 | Trigalacturonic acid | NQ |
| 5 | 5.37 | 443.1907 | C21H32O10 | Penstemide | NQ |
| 6 | 6.02 | 351.0711 | C16H16O9 | Chlorogenoquinone isomer 1 | NQ |
| 7 | 6.02 | 173.0445 | C21H32O10 | Shikimic acid | NQ |
| 8 | 6.27 | 351.0717 | C16H16O9 | Chlorogenoquinone isomer 2 | NQ |
| 9 | 6.80 | 289.0704 | C15H14O6 | (Epi)catechin | 7 ± 2 |
| 10 | 7.19 | 577.4579 | C30H26O12 | Procyanidin B dimer | NQ |
| 11 | 7.89 | 865.1994 | C45H38O18 | Procyanidin B trimer isomer 1 | 2.1 ± 0.2 |
| 12 | 8.22 | 1153.2635 | C60H50O24 | Procyanidin B tetramer isomer 1 | 1.31 ± 0.10 |
| 13 | 8.55 | 865.1959 | C45H38O18 | Procyanidin B trimer isomer 2 | NQ |
| 14 | 8.64 | 441.1741 | C21H30O10 | Hydroxyabscisic acid glucoside | NQ |
| 15 | 8.85 | 863,1796 | C45H36O13 | Procyanidin A trimer | 2.8 ± 0.3 |
| 16 | 8.97 | 1153.2576 | C60H50O24 | Procyanidin B tetramer isomer 2 | 2.1 ± 0.2 |
| 17 | 9.11 | 521.2003 | C26H34O11 | Isolariciresinol glucid derivative | NQ |
| 18 | 9.23 | 625.1390 | C27H30O17 | Quercetin diglucoside isomer 1 | 3.9 ± 0.3 |
| 19 | 9.33 | 625.1389 | C27H30O17 | Quercetin diglucoside isomer 2 | 0.7 ± 0.1 |
| 20 | 9.57 | 565.2265 | C28H38O12 | Quercetin derivative isomer 1 | 1.48 ± 0.09 |
| 21 | 9.81 | 595.1292 | C26H28O16 | Quercetin arabinosyl glucoside isomer 1 | 3.4 ± 0.3 |
| 22 | 9.90 | 595.1311 | C26H28O16 | Quercetin arabinosyl glucoside isomer 2 | 0.6 ± 0.2 |
| 23 | 10.00 | 609.1468 | C27H30O16 | Quercetin rutinoside isomer 1 | 1.79 ± 0.09 |
| 24 | 10.03 | 505.2083 | C23H22O13 | Quercetin acetylglucoside | 1.10 ± 0.07 |
| 25 | 10.08 | 575.1190 | C30H24O12 | Procyanidin A dimer isomer 1 | 2.2 ± 0.2 |
| 26 | 10.33 | 575.1185 | C30H24O12 | Procyanidin A dimer isomer 2 | 2.0 ± 0.2 |
| 27 | 10.36 | 595.1302 | C26H28O16 | Quercetin arabinosyl glucoside isomer 3 | 0.53 ± 0.07 |
| 28 | 10.49 | 463.0859 | C21H20O12 | Quercetin glucoside isomer 1 | 1.5 ± 0.1 |
| 29 | 10.62 | 463.0849 | C21H20O12 | Quercetin glucoside isomer 2 | 0.55 ± 0.07 |
| 30 | 10.73 | 579.1335 | C26H28O16 | Luteolin pentosyl hexoside | 2.1 ± 0.2 |
| 31 | 10.93 | 565.1187 | C28H38O12 | Quercetin derivative isomer 2 | 0.52 ± 0.02 |
| 32 | 11.00 | 299.0178 | C15H8O7 | Norwedelactone | NQ |
| 33 | 11.08 | 609.1468 | C27H30O16 | Quercetin rutinoside isomer 2 | 9.6 ± 0.7 |
| 34 | 11.18 | 447.0891 | C21H20O11 | Quercetin rhamnoside isomer 1 | 0.52 ± 0.05 |
| 35 | 11.32 | 433.0750 | C20H18O11 | Quercetin arabinoside | <LOQ |
| 36 | 11.48 | 447.0919 | C21H20O11 | Quercetin rhamnoside isomer 2 | <LOQ |
| 37 | 11.72 | 447.0905 | C21H20O11 | Quercetin rhamnoside isomer 3 | 0.79 ± 0.09 |
| 38 | 11.77 | 285.0393 | C15H10O6 | Luteolin | 0.36 ± 0.02 |
| 39 | 11.89 | 579.1340 | C26H28O15 | Quercetin xylosyl rhamnoside | 1.96 ± 0.05 |
| 40 | 11.98 | 593.1517 | C27H30O15 | Kaempferol glucosyl rhamnoside | 1.89 ± 0.09 |
| 41 | 12.01 | 341.1376 | C20H22O5 | Obovatifol | NQ |
| 42 | 12.06 | 315.0488 | C16H12O7 | Isorhamnetin | 1.1 ± 0.1 |
| 43 | 12,53 | 575.1195 | C30H24O12 | Procyanidin A dimer isomer 3 | <LOQ |
| 44 | 12,81 | 563.1403 | C26H28O14 | Apigenin glucoside derivative | <LOQ |
| 45 | 13.04 | 585.2366 | C24H42O16 | Glycosidic derivative | NQ |
| 46 | 13.70 | 697.2519 | C36H42O14 | Lariciresinol feruloyl glucopyranoside | 0.38 ± 0.02 |
| 47 | 14.37 | 327.2166 | C18H32O5 | Fatty acid | NQ |
| 48 | 14.54 | 383.1488 | - | Unknown | NQ |
| 49 | 14.57 | 285.0391 | C15H10O6 | Kaempferol | 0.38 ± 0.07 |
| 50 | 15.03 | 329.2313 | C18H34O5 | Trihydroxyoctadecenoic acid | NQ |
| 51 | 15.97 | 329.2317 | C18H34O5 | Trihydroxyoctadecenoic acid | NQ |
|
|
| ||||
RT: retention time; DE: dry extract.
Evaluation of total phenolic content, antioxidant capacity, radical scavenging and enzymatic inhibition of avocado by-product extracts.
| Methodology | AS Extract | AP Extract |
|---|---|---|
|
| 60 ± 2 | 190 ± 3 |
|
| 0.393 ± 0.005 | 1.427 ± 0.002 |
|
| 496 ± 2 | 1510 ± 1 |
|
| 0.57 ± 0.02 | 1.78 ± 0.05 |
|
| 2.3 ± 0.1 | 7.1 ± 0.2 |
|
| 656 ± 4 | 380 ± 69 |
|
| 4.5 ± 0.6 | 1.90 ± 0.09 |
|
| 58.3 ± 0.8 | 67 ± 4 |
|
| - | 158 ± 7 |
|
| 6.3 ± 0.7 | 4 ± 1 |
|
| 790 ± 50 | 475 ± 2 |
|
| 7 ± 1 | 8 ± 1 |
|
| 104 ± 8 | 81 ± 1 |
AS: avocado seed; AP: avocado peel; FRAP: ferric reducing antioxidant power assay; TEAC: Trolox equivalent antioxidant capacity; ORAC: oxygen radical absorbance capacity; GAE: gallic acid equivalent; DE: dry extract; TE: Trolox equivalent. Data are means ± standard deviation (n = 3). 1 Inhibitory concentration at 50%. 2 Inhibitory concentration at 30%.
Positive controls from radical scavenging and enzymatic inhibitions.
| Methodology | GA | EPI | PHY | PHE | ELA | KA |
|---|---|---|---|---|---|---|
|
| 3.8 ± 0.3 | 0.18 ± 0.01 | X | X | X | X |
|
| 50 ± 3 | 70 ± 5 | X | X | X | X |
|
| 1.4 ± 0.3 | 0.87 ± 0.02 | X | X | X | X |
|
| X | X | 0.043 ± 0.004 | X | X | X |
|
| X | X | X | X | X | 49 ± 6 |
|
| X | 9 ± 1 | X | X | X | X |
|
| X | X | X | X | 53 ± 5 | X |
|
| <10 | <10 | X | X | X | X |
|
| X | X | X | 83 ± 2 | X | X |
GA: gallic acid; EPI: epicatechin; PHY: physostigmine; PHE: 1, 10-phenanthroline; ELA: elastatinal; KA: Kojic acid; inh.: inhibition. 1 Inhibitory Concentration at 50%. 2 Inhibitory Concentration at 90%. 3 At 21.3 mg/L. 4 At 51.26 mg/L. 5 From 6 to 220 mg/L. 6 At 4500 mg/L.
Evaluation of platelet-aggregation inhibition of avocado seed and peel against thrombus-formation agonists TRAP-6, ADP and collagen.
| Extracts | TRAP-6 (10 μM) | ADP (4 μM) | Collagen (1 μg/mL) | |||
|---|---|---|---|---|---|---|
| PA (%) | Inh. (%) | PA (%) | Inh. (%) | PA (%) | Inh. (%) | |
|
| 85 ± 1 ns | 0 | 89 ± 1 ns | 3 ± 1 | 40 ± 6 *** | 45 ± 2 |
|
| 45 ± 1 *** | 42 ± 1 | 20 ± 2 *** | 78 ± 2 | 32 ± 6 *** | 55 ± 2 |
|
| 88 ± 1 | 0 | 94 ± 1 | 0 | 82 ± 3 | 0 |
|
| 22 ± 3 | 79 ± 2 | 27 ± 4 | 69 ± 4 | 27 ± 1 | 59 ± 2 |
Results are expressed as mean ± SEM, n = 5. Data were analysed by one-way ANOVA. Post hoc analyses were performed using Dunnet’s test, *** p < 0.001 denotes statistically significant differences compared to the negative control (vehicle). ns: denotes nonstatistical differences with respect to the vehicle. ADP: adenosine diphosphate, Inh: inhibition, PA: percentage of platelet aggregation, SEM: standard error, TRAP-6: thrombin-6 receptor-activating peptide.
Figure 1Study of platelet aggregation of avocado peel and seed extract induced by collagen and ADP. The PRP was previously incubated with vehicle or avocado extract (0.1, 0.25, 0.50, 0.75 and 1 mg/mL). After 3 minutes of incubation at 37 °C, it was stimulated with the agonist to initiate platelet aggregation for 6 minutes. The negative control is in the absence of the extracts. Bar graph indicates maximum aggregation expressed as a percentage (mean ± SEM; n = 6). Differences between groups were analysed by ANOVA using Dunnet’s post hoc test. *** p < 0.001 and ** p < 0.01, denote statistically significant differences compared to the vehicle; ns: nonstatistical difference with respect to the vehicle (PBS).
Figure 2Effect of avocado-peel extract on the expression of platelet-activation markers. (A) Effect on P-selectin expression; (B) Effect on PAC-1 expression. Platelets were stimulated with ADP or Collagen. Platelets were identified as a CD61 + population. Statistical analysis was performed by ANOVA (Dunnet’s test). * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. Vehicle (PBS) vs. activated control (agonist) (n = 5).